Semantically enabling pharmacogenomic data for the realization of personalized medicine.

@article{Samwald2012SemanticallyEP,
  title={Semantically enabling pharmacogenomic data for the realization of personalized medicine.},
  author={Matthias Samwald and Adrien Coulet and Iker Huerga and Robert L. Powers and Joanne S. Luciano and Robert R. Freimuth and Frederick Whipple and Elgar Pichler and Eric Prud'hommeaux and Michel Dumontier and M. Scott Marshall},
  journal={Pharmacogenomics},
  year={2012},
  volume={13 2},
  pages={
          201-12
        }
}
Understanding how each individual's genetics and physiology influences pharmaceutical response is crucial to the realization of personalized medicine and the discovery and validation of pharmacogenomic biomarkers is key to its success. However, integration of genotype and phenotype knowledge in medical information systems remains a critical challenge. The inability to easily and accurately integrate the results of biomolecular studies with patients' medical records and clinical reports prevents… 

Figures and Tables from this paper

The real informatics challenges of personalized medicine: not just about the number of central processing units.
TLDR
Managing patient omic profiles has created a bottleneck due to the limitations in storage, computing power and information access, the lack of biologist-friendly software to replace the user-unfriendly custom scripts, which are crippling collaboration and unavailability of a robust, integrative workflow system.
Translational bioinformatics approaches for systems and dynamical medicine.
  • Qing Yan
  • Biology
    Methods in molecular biology
  • 2014
TLDR
Data integration, data mining, and knowledge discovery methods would enable the simulation of complex systems and dynamical networks to establish predictive models for achieving predictive, preventive, and personalized medicine.
Learning from biomedical linked data to suggest valid pharmacogenes
TLDR
A selection and linkage of data sources relevant to pharmacogenomics, including for example DisGeNET and Clinvar are proposed, which use machine learning to identify and prioritize pharmacogenes that are the most probably valid, considering the selected linked data.
Suggesting Valid Pharmacogenes by Mining Linked Data
TLDR
A novel method that consumes an eclectic set of linked data sources to help validating uncertain drug–gene relationships and produces a model that enables classifying drug–Gene pairs as related or not, thus confirming the validity of candidate pharmacogenes.
User-centered design and evaluation of a pharmacogenomics information portal to support clinical decision-making
TLDR
This work developed a detailed and clinically relevant pharmacogenomics semantic model to annotate FDA product labels and demonstrates the effectiveness of using qualitative methods to design clinically relevant Pharmacogenomics information resources that are highly usable by clinicians.
Pharmacogenomics in the pocket of every patient? A prototype based on quick response codes
TLDR
The medicine safety code (MSC) is introduced, which captures compressed pharmacogenomic data in a two-dimensional barcode that can be carried in a patient's wallet and successfully encoded data about 385 genetic polymorphisms in MSC and were able to decode and interpret MSC quickly with common mobile devices.
Applying linked data approaches to pharmacology: Architectural decisions and implementation
TLDR
This application report describes a linked data platform for integrating multiple pharmacology datasets that form the basis for several drug discovery applications, drawn from a collection of prioritised drug discovery business questions created as part of the Open PHACTS project.
Electronic health record design and implementation for pharmacogenomics: a local perspective
TLDR
The design of a locally developed electronic health record supporting pharmacogenomics has generalizable utility and the challenge of representing genomic data in a comprehensible and clinically actionable format is discussed along with reflection on the scalability of the model to larger sets of genomic data.
...
1
2
...

References

SHOWING 1-10 OF 51 REFERENCES
Towards pharmacogenomics knowledge discovery with the semantic web
TLDR
Progress in this area is illustrated with reference to the personalized medicine project that aims to facilitate pharmacogenomics knowledge discovery through intuitive knowledge capture and sophisticated question answering using automated reasoning over expressive ontologies.
The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside
TLDR
This work describes a collaborative effort to produce a prototype Translational Medicine Knowledge Base capable of answering questions relating to clinical practice and pharmaceutical drug discovery and demonstrates the use of Semantic Web technologies in the integration of patient and biomedical data.
Ontology-based knowledge discovery in pharmacogenomics.
TLDR
The potential of KR and KD processes are shown, especially for designing KB, checking KB consistency, and reasoning for problem solving, on a clinical trial concerned with the variability of drug response to montelukast treatment.
A Standard Based Approach for Biomedical Knowledge Representation
TLDR
This paper describes a methodology used in Hypergenes, an EC FP7 project targeting Essential Hypertension, which captures data and knowledge using standards such as HL7 CDA and Clinical Genomics, aligned with the CEN EHR 13606 specification.
Integrating genotype and phenotype information: an overview of the PharmGKB project
TLDR
This work has shown that individuals with a genetic variation for the enzyme thiopurine methyltransferase do not need lower doses of 6-mercaptopurine for effective treatment as normal doses can be lethal.
Towards an Interoperable Information Infrastructure Providing Decision Support for Genomic Medicine
TLDR
The work and future visions around the creation of a distributed infrastructure for pharmacogenetic data and medical decision support, based on industry standards such as the Web Ontology Language (OWL) and the Arden Syntax are described.
Developing a kidney and urinary pathway knowledge base
TLDR
A Semantic Web approach to developing a knowledge base that integrates data from high-throughput experiments on kidney and urine and using SPARQL as a query mechanism gives KUP biologists the means to ask queries across many resources in order to aggregate knowledge that is necessary for answering biological questions.
Recent progress in automatically extracting information from the pharmacogenomic literature.
TLDR
The main tasks of text mining in the context of pharmacogenomics are described, recent applications are summarized and the next phase of textmining applications are anticipated.
Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text
TLDR
The Pharmspresso tool is a text analysis tool that extracts pharmacogenomic concepts from the literature automatically and thus captures the current understanding of gene-drug interactions in a computable form.
...
1
2
3
4
5
...